Alessandro Livieri

Title: The Innovative Contributions of Alessandro Livieri

Introduction

Alessandro Livieri is a notable inventor based in Pavia, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on improving the efficacy and delivery of medications for respiratory conditions.

Latest Patents

Livieri holds a patent for a crystalline form of tiotropium bromide with lactose. This cocrystal combines tiotropium bromide and lactose monohydrate in an almost stoichiometric ratio. The cocrystal exhibits a single endothermic event at approximately 191-193°C, as determined by differential scanning calorimetry (DSC). The preparation process for this cocrystal is also disclosed in the patent. It is designed for use as a medicament, particularly for treating respiratory complaints such as chronic obstructive pulmonary disease (COPD), bronchitis, emphysema, and asthma. The pharmaceutical composition containing this cocrystal is intended for inhalation, with a mean particle size ranging from 0.5 to 10 micrometers.

Career Highlights

Alessandro Livieri is currently employed at Euticals Spa, where he continues to advance his research and development efforts in the pharmaceutical industry. His innovative approach to drug formulation has positioned him as a key player in the field.

Collaborations

Livieri collaborates with talented colleagues, including Paride Grisenti and Maria Argese. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical innovations.

Conclusion

Alessandro Livieri's contributions to the field of pharmaceuticals, particularly through his patent for a cocrystal formulation, highlight his innovative spirit and dedication to improving respiratory treatments. His work continues to impact the industry positively.